Melatonin as a putative protection against myocardial injury in COVID-19 infection.

Simko, Fedor; Hrenak, Jaroslav; Dominguez-Rodriguez, Alberto; Reiter, Russel J

Simko, Fedor; Hrenak, Jaroslav; Dominguez-Rodriguez, Alberto; Reiter, Russel J.

Simko F; Institute of Pathophysiology, Faculty of Medicine, Comenius University , Bratislava, Slovak Republic.
Hrenak J; 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University , Bratislava, Slovak Republic.
Dominguez-Rodriguez A; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences , Bratislava, Slovak Republic.
Reiter RJ; Institute of Pathophysiology, Faculty of Medicine, Comenius University , Bratislava, Slovak Republic.

Expert Rev Clin Pharmacol ; 13(9): 921-924, 2020 Sep.

Article in English | MEDLINE | ID: covidwho-745878

Subject(s)

Betacoronavirus; Coronavirus Infections/complications; Heart Diseases/etiology; Heart Diseases/prevention & control; Melatonin/therapeutic use; Pneumonia, Viral/complications; COVID-19; Humans; Melatonin/metabolism; Pandemics; SARS-CoV-2

Keywords

COVID-19; RAS; SARS-CoV-2; acute myocardial injury; antiinflammation; antioxidant; cytokine storm; melatonin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Heart Diseases / Melatonin Topics: Long Covid Limits: Humans Language: English Journal: Expert Rev Clin Pharmacol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google